There were 752 press releases posted in the last 24 hours and 398,031 in the last 365 days.

Investigation Into Cibus, Inc. (CBUS) Announced by Holzer & Holzer, LLC

ATLANTA, June 05, 2024 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Cibus, Inc. (“Cibus” or the “Company”) (NASDAQ: CBUS) complied with federal securities laws. On June 4, 2024, Bonitas Research published a report alleging, among other things, that “investors have been duped into believing a promotional management team about an over-hyped technology previously tried, tested, and failed by some of the world’s largest seed manufacturers and distributors to provide exit liquidity for early-stage Cibus investors.” Following this news, the price of the Company’s stock dropped.

If you purchased Cibus stock and suffered a loss on that investment, you are encouraged to contact Corey Holzer, Esq. at  cholzer@holzerlaw.com  or Joshua Karr, Esq. at jkarr@holzerlaw.com, call our toll-free number at (888) 508-6832, or visit our website at http://holzerlaw.com/case/cibus/ to discuss your legal rights.  

Holzer & Holzer, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, www.holzerlaw.com, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.  

CONTACT:
Corey Holzer, Esq. 
(888) 508-6832 (toll-free)  
cholzer@holzerlaw.com


Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.